Publication | Closed Access

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

Hematological MalignancyOncologyMedicineInitial TreatmentHematologyClinical TrialsMyeloid NeoplasiaMultiple MyelomaPharmacotherapyVad-doxil Versus Vad-doxilPharmacologyHealth Sciences